• Brexanolone produces ‘meaningful reductions' in postpartum depression

    11 days ago - By Healio

    Most women who received an injection of brexanolone - a positive allosteric modulator of -aminobutyric-acid type A receptors - for postpartum depression had significant and clinically meaningful reductions of the condition at 60 hours vs. placebo, according to findings recently published in The Lancet.
    “To date, no pharmacological therapies have been developed specifically for postpartum depression. Thus, improved pharmacological treatment options are urgently needed,” Samantha Meltzer-Brody, MD, MPH, of the department of psychiatry at the University of North Carolina
    Read more ...